Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2010, 3(12), 3581-3593; doi:10.3390/ph3123581
Review

Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress

1,*  and 2
Received: 15 November 2010; in revised form: 8 December 2010 / Accepted: 9 December 2010 / Published: 14 December 2010
(This article belongs to the Special Issue New Antimalarial Drugs)
View Full-Text   |   Download PDF [205 KB, uploaded 14 December 2010]
Abstract: With the rapidly spreading resistance of Plasmodium falciparum to available non-artemisinin antimalarial drugs, new and novel pharmaceuticals are needed. ARCO® is a new generation ACT, one of several artemisinin-based combinations developed in China to counter antimalarial drug resistance. ARCO® is a derivative of two independently developed antimalarials, artemisinin and naphthoquine phosphate, which were combined to form the artemisinin-naphthoquine combination. Both artemisinin and naphthoquine drugs have proven to be efficacious, safe and well tolerated as monotherapies. The artemisinin-naphthoquine combination offers a novel advantage over existing ACTs: it can be administered as a single oral dose (or a 1-day treatment). Several therapeutic studies conducted recently indicate that a single oral dose administration of artemisinin-naphthoquine combination is equally effective and safe as the 3-day treatment with artemether-lumefantrine combination and other existing ACTs. This would make ARCO® the next generation ACT for the treatment of uncomplicated falciparum malaria.
Keywords: artemisinin-naphthoquine combination; ARCO; artemisinin; naphthoquine; Plasmodium falciparum artemisinin-naphthoquine combination; ARCO; artemisinin; naphthoquine; Plasmodium falciparum
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Hombhanje, F.W.; Huang, Q. Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress. Pharmaceuticals 2010, 3, 3581-3593.

AMA Style

Hombhanje FW, Huang Q. Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress. Pharmaceuticals. 2010; 3(12):3581-3593.

Chicago/Turabian Style

Hombhanje, Francis W.; Huang, Qingyun. 2010. "Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress." Pharmaceuticals 3, no. 12: 3581-3593.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert